✦ LIBER ✦

PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK: A Cost-Utility Analysis

✍ Scribed by Taylor, M.; Serbetci, E.; Ferreira, A.; Gairy, K.; Blouin, J.; Mitchell, P.; Lewis, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS20 Cost-Utility Analysis of Treatment

✍ Duff, S.; Gricar, J.; Kymes, S.; Tran, I.; Turpcu, A.; Sternberg, G. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PSS13 INCREMENTAL COST-UTILITY ANALYSIS

✍ J. Kowalski; W.S. Yeh; B. O'Leary; S. Ackerman; S. Sharma; M. Adena 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PSS19 Economic Evaluation of Ranibizumab

✍ Haig, J.; Lawrence, D.; Barbeau, M.; Blouin, J.; Zaour, N. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Ranibizumab for Macular Edema Due to Ret

✍ Jeffrey S. Heier; Peter A. Campochiaro; Linda Yau; Zhengrong Li; Namrata Saroj; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 476 KB

Two-Year Results of Intravitreal Triamci

✍ Figen Batioglu; Emin Özmert; Elif Akmese 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 317 KB

Compassionate use of dexamethasone impla

✍ Maurizio Battaglia Parodi; Pierluigi Iacono; Marialucia Cascavilla; Ilaria Zucch 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 204 KB